openPR Logo

Press Releases from DelveInsight Business Research LLP (4751 total)

Cervical Dysplasia Market to Show Remarkable Growth Trends from 2024 to 2034, De …

DelveInsight's "Cervical Dysplasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cervical Dysplasia, historical and forecasted epidemiology as well as

Gender Dysphoria Market Growth to Accelerate in Forecast Period (2024-2034), Del …

DelveInsight's "Gender Dysphoria Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Gender Dysphoria, historical and forecasted epidemiology as well as

Hepatitis B Market to Reach New Heights in Growth by 2032, DelveInsight Predicts …

DelveInsight's "Hepatitis B Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hepatitis B, historical and forecasted epidemiology as well as

Endometriosis Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, Th …

"Endometriosis Pipeline Insight" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Endometriosis Market. The Endometriosis Pipeline report

Metastatic HR+/HER2- Breast Cancer Market: Analysis of Epidemiology, Pipeline Pr …

Metastatic HR+/HER2- Breast Cancer emerging therapies such as KISQALI (ribociclib), PIQRAY (alpelisib), ARV-471 (vepdegestrant), OP1250 (palazestrant), and others are expected to boost the Metastatic HR+/HER2-

ER+/HER2- Breast Cancer Market: Analysis of Epidemiology, Pipeline Products, and …

ER+/HER2- Breast Cancer emerging therapies such as KISQALI (ribociclib), IBRANCE (palbociclib), AFINITOR (everolimus), LYNPARZA (olaparib), Elacestrant, Giredestrant (RG6171, GDC-9545), Camizestrant (AZD9833), LY3484356 (imlunestrant), Lerociclib (EQ132),

Chondrosarcoma Market: Analysis of Epidemiology, Pipeline Products, and Key Comp …

Chondrosarcoma emerging therapies such as INBRX-109, TIBSOVO (ivosidenib), and others are expected to boost the Chondrosarcoma Market in the upcoming years. DelveInsight has launched a new

Cancer Cachexia Market: Analysis of Epidemiology, Pipeline Products, and Key Com …

Cancer Cachexia emerging therapies are expected to boost the Cancer Cachexia Market in the upcoming years. DelveInsight has launched a new report on "Cancer Cachexia -

Venous Thromboembolism Treatment Market Size is anticipated to grow with a signi …

DelveInsight's "Venous Thromboembolism Market Insights, Epidemiology, and Market Forecast 2034" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as

Ulcerative Colitis Market Size was ~USD 8,400 million in 2023 and is anticipated …

DelveInsight's "Ulcerative Colitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Ulcerative Colitis, historical and forecasted epidemiology as well as

Psoriasis Therapeutics Market Size in the 7MM is expected to increase a signific …

DelveInsight's "Psoriasis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis

Tendinopathy Treatment Market Size in the 7MM is expected to grow with a signifi …

DelveInsight's "Tendonitis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis

Chondrosarcoma Treatment Market Size in the 7MM was ~USD 8.5 Million in 2023, is …

DelveInsight's "Chondrosarcoma Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Chondrosarcoma, historical and forecasted epidemiology as well as the Chondrosarcoma market

Gastroenteropancreatic Neuroendocrine Tumors Market: Analysis of Epidemiology, P …

Gastroenteropancreatic Neuroendocrine Tumors emerging therapies such as TransCon hGH, HyTropin (GX-H9), Somatrogon, and others are expected to boost the Gastroenteropancreatic Neuroendocrine Tumors Market in the

Metastatic HER2 positive Breast Cancer Market: Analysis of Epidemiology, Pipelin …

Metastatic HER2 positive Breast Cancer emerging therapies such as HERCEPTIN, PERJETA, KADCYLA, ENHERTU, and others are expected to boost the Metastatic HER2 positive Breast Cancer

Melanoma Market: Analysis of Epidemiology, Pipeline Products, and Key Companies …

Melanoma emerging therapies such as AMTAGVI (lifileucel), OPDIVO (nivolumab), Fianlimab + Cemiplimab, IO102-IO103 + KEYTRUDA, and others are expected to boost the Melanoma Market in

Metastatic Castration-Resistant Prostate Cancer Market: Analysis of Epidemiology …

Metastatic Castration-Resistant Prostate Cancer emerging therapies such as JEVTANA (Cabazitaxel), XOFIGO (radium-223), Opevesostat (MK-5684; ODM-208), TRUQAP (capivasertib, AZD 5363), and others are expected to boost

PEComa Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Wo …

PEComa emerging therapies such as FYARRO (sirolimus protein-bound), and others are expected to boost the PEComa Market in the upcoming years. DelveInsight has launched a new

Antibody Drug Conjugate Competitie Landscape Report (Updated) | ImmunoGen, Inc., …

DelveInsight's, "Antibody Drug Conjugate Competitive landscape, 2025," report provides comprehensive insights about 180+ companies and 290+ drugs in Antibody Drug Conjugate Competitive landscape. It covers

Bispecific Antibody Competitive Landscape Report 2025 | Janssen, Amgen, Akeso, Z …

DelveInsight's, "Bispecific antibody - Competitive landscape, 2025," report provides comprehensive insights about 180+ companies and 250+ drugs in Bispecific antibody Competitive landscape. It covers the

Cholangiocarcinoma Treatment Market Size in the 7MM is expected to grow a signif …

DelveInsight's "Cholangiocarcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cholangiocarcinoma, historical and forecasted epidemiology as well as the Cholangiocarcinoma

Autism Spectrum Disorder Treatment Market Size is expected to experience steady …

DelveInsight's "Autism Spectrum Disorder Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Autism Spectrum Disorder, historical and forecasted epidemiology as

Biliary Tract Cancer Market: Analysis of Epidemiology, Pipeline Products, and Ke …

Biliary Tract Cancer emerging therapies such as PEMAZYRE (pemigatinib), IMFINZI (durvalumab), CTX-009, Zanidatamab, and others are expected to boost the Biliary Tract Cancer Market in

Adenoid Cystic Carcinoma Market: Analysis of Epidemiology, Pipeline Products, an …

Adenoid Cystic Carcinoma emerging therapies such as lenvatinib, pembrolizumab, AL101, and others are expected to boost the Adenoid Cystic Carcinoma Market in the upcoming years. DelveInsight

Acute Lymphocytic Leukemia Market: Analysis of Epidemiology, Pipeline Products, …

Acute Lymphocytic Leukemia emerging therapies such as BLINCYTO, GLEEVEC, ICLUSIG, RITUXAN, BESPONSA, KYMRIAH, TECARTUS, WU-CART-007, Obecabtagene autoleucel, SNDX-561, and others are expected to boost the

Urothelial Carcinoma Market: Analysis of Epidemiology, Pipeline Products, and Ke …

Urothelial Carcinoma emerging therapies such as KEYTRUDA (pembrolizumab), OPDIVO (nivolumab), BT8009, Erdafitinib and Cetrelimab, and others are expected to boost the Urothelial Carcinoma Market in

Tenosynovial Giant Cell Tumors Market: Analysis of Epidemiology, Pipeline Produc …

Tenosynovial Giant Cell Tumors emerging therapies such as TURALIO (pexidartinib), Vimseltinib (DCC-3014), and others are expected to boost the Tenosynovial Giant Cell Tumors Market in

Myelodysplastic Syndrome Clinical Trials and Studies: EMA, PDMA, FDA Approvals, …

DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Treatment Market Size …

DelveInsight's "ANCA Associated Vasculitis Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the ANCA Associated Vasculitis, historical and forecasted

Allergic Rhinoconjunctivitis Treatment Market Size in the 7MM is expected to inc …

DelveInsight's "Allergic Rhinoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Allergic Rhinoconjunctivitis, historical and forecasted epidemiology as well as

Primary Sclerosing Cholangitis Treatment Market Size in the 7MM is expected to g …

DelveInsight's 'Primary Sclerosing Cholangitis Market Insights, Epidemiology, and Market Forecast - 2032' report delivers an in-depth understanding of the Primary Sclerosing Cholangitis, historical and forecasted

Acquired hemophilia A Treatment Market Size in the 7MM is expected to increase a …

DelveInsight's "Acquired hemophilia A Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Acquired hemophilia A, historical and forecasted epidemiology as

Uveal melanoma Market: Analysis of Epidemiology, Pipeline Products, and Key Comp …

Uveal melanoma emerging therapies such as Melphalan, Defacitinib (VS-6063) + VS-6766 (VH5126766), Ulixertinib (BVD-523), Binimetinib + Belinostat, and others are expected to boost the Uveal

Intrahepatic Cholangiocarcinoma Market: Analysis of Epidemiology, Pipeline Produ …

Intrahepatic Cholangiocarcinoma emerging therapies such as PEMAZYRE (pemigatinib), ROZLYTREK (entrectinib), TIBSOVO (ivosidenib), CTX-009, Tinengotinib, Silmitasertib (CX-4945), and others are expected to boost the Intrahepatic Cholangiocarcinoma

TRK Fusion Cancer Market: Analysis of Epidemiology, Pipeline Products, and Key C …

TRK Fusion Cancer emerging therapies are expected to boost the TRK Fusion Cancer Market in the upcoming years. DelveInsight has launched a new report on "TRK

Non-Small Cell Lung Cancer Market: Analysis of Epidemiology, Pipeline Products, …

Non-Small Cell Lung Cancer emerging therapies such as TransCon hGH, HyTropin (GX-H9), Somatrogon, and others are expected to boost the Non-Small Cell Lung Cancer Market

Relapsing Refractory Multiple Myeloma Market: Analysis of Epidemiology, Pipeline …

Relapsing Refractory Multiple Myeloma emerging therapies are expected to boost the Relapsing Refractory Multiple Myeloma Market in the upcoming years. DelveInsight has launched a new report

Alpha-1 Protease Inhibitor Deficiency Therapeutics Market Size in the 7MM is exp …

DelveInsight's "Alpha-1 Protease Inhibitor Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Alpha-1 Protease Inhibitor Deficiency, historical and forecasted

Amyloidosis Treatment Market Size in the 7MM is expected to increase a significa …

DelveInsight's "Amyloidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Amyloidosis, historical and forecasted epidemiology as well as the Amyloidosis

Basal Cell Nevus Syndrome Treatment Market Size in the 7MM is expected to grow a …

DelveInsight's "Basal Cell Nevus Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Nevus Syndrome, historical and forecasted

Biliary Atresia Therapeutics Market Size is expected to increase a significant C …

DelveInsight's "Biliary Atresia Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Biliary Atresia, historical and forecasted epidemiology as

Cryopyrin-associated Periodic Syndromes Treatment Market Size in the 7MM is expe …

DelveInsight's "Cryopyrin-associated Periodic Syndromes Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cryopyrin-associated Periodic Syndromes, historical and forecasted epidemiology as

Opioid Use Disorder Treatment Market Size in the 7MM was around USD 2,000 millio …

DelveInsight's "Opioid Use Disorder Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Opioid Use Disorder, historical and forecasted epidemiology

Attention Deficit Hyperactivity Disorder Treatment Market Size in the 7MM is exp …

DelveInsight's "Attention Deficit Hyperactivity Disorder Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Attention Deficit Hyperactivity Disorder, historical and forecasted

Vasculitis Treatment Market Size Report 2032 | Human Genome Sciences Inc., a GSK …

DelveInsight's "Vasculitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vasculitis, historical and forecasted epidemiology as well as the Vasculitis

Tuberous Sclerosis Complex Therapeutics Market Size Report 2034 | Jazz Pharmaceu …

DelveInsight's "Tuberous Sclerosis Complex Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Tuberous Sclerosis Complex, historical and forecasted epidemiology as

Gastroparesis Therapeutics Market Size Report 2034 | Vanda Pharmaceuticals, Proc …

DelveInsight's "Gastroparesis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Gastroparesis, historical and forecasted epidemiology as well as the Gastroparesis

Messenger RNA Treatment Market Size Report 2032 | Translate Bio, AstraZeneca/Mod …

DelveInsight's "Messenger RNA Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Global Messenger RNA, historical and forecasted epidemiology as well

Diabetes Treatment Market Size Report 2032 | Enthera, Nano Precision Medical, Or …

DelveInsight's "Diabetes Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Diabetes, historical and forecasted epidemiology as well as the Diabetes

Osteoarthritis Clinical and Non-Clinical Studies, Key Companies, Therapeutic Ass …

Osteoarthritis Pipeline constitutes 100+ key companies continuously working towards developing 110+ Osteoarthritis treatment therapies, analyzes DelveInsight. Osteoarthritis Overview: Osteoarthritis (OA) is the most prevalent type of arthritis,

Go To Page:    11 12 13 14 15 16 17 18 19 20